Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia

被引:32
作者
Gu, Fangyi [1 ,2 ]
Zhang, Han [1 ]
Hyland, Paula L. [1 ]
Berndt, Sonja [1 ]
Gapstur, Susan M. [3 ]
Wheeler, William [4 ]
Amos, Christopher I. [5 ]
Bezieau, Stephane [6 ]
Bickeboller, Heike [7 ]
Brenner, Hermann [8 ,9 ,10 ,11 ]
Brennan, Paul [12 ]
Chang-Claude, Jenny [13 ]
Conti, David V. [14 ]
Doherty, Jennifer Anne [15 ]
Gruber, Stephen B. [14 ]
Harrison, Tabitha A. [16 ]
Hayes, Richard B. [17 ]
Hoffmeister, Michael [8 ]
Houlston, Richard S. [18 ]
Hung, Rayjean J. [19 ]
Jenkins, Mark A. [20 ]
Kraft, Peter [21 ]
Lawrenson, Kate [22 ]
Mckay, James [12 ]
Markt, Sarah [21 ]
Mucci, Lorelei [21 ]
Phelan, Catherine M. [23 ]
Qu, Conghui [16 ]
Risch, Angela [24 ,25 ,26 ,27 ,28 ]
Rossing, Mary Anne [16 ]
Wichmann, H. -Erich [29 ,30 ,31 ]
Shi, Jianxin [1 ]
Schernhammer, Eva [21 ,32 ,33 ]
Yu, Kai [1 ]
Landi, Maria Teresa [1 ]
Caporaso, Neil E. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
[2] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
[3] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
[4] Informat Management Serv Inc, Rockville, MD USA
[5] Geisel Dartmouth Med Sch, Lebanon, NH USA
[6] CHU Nantes, Serv Gertet Med, Nantes, France
[7] Univ Med Ctr Gottingen, Dept Genet Epidemiol, Gottingen, Germany
[8] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[9] Natl Ctr Tumor Dis NCI, Div Prevent Oncol, Heidelberg, Germany
[10] German Canc Res Ctr, Heidelberg, Germany
[11] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[12] Int Agcy Res Canc, Lyon, France
[13] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[14] Univ South Calif, Keck Sch Med, Los Angeles, CA USA
[15] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[16] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
[17] NYU, Sch Med, Dept Popubat Hlth, New York, NY USA
[18] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England
[19] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[20] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic, Australia
[21] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[22] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[23] H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Dept Canc Epidemiol, Tampa, FL USA
[24] Univ Salzburg, Div Mol Biol, Salzburg, Austria
[25] Canc Cluster Sarzburg, Salzburg, Austria
[26] Translat Lung Res Ctr, Heidelberg, Germany
[27] German Ctr Lung Res DZL, Giessen, Germany
[28] DKFZ German Canc Res Ctr, Div Epigen & Canc Risk Factors, Leidelberg, Germany
[29] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Bavaria, Germany
[30] Helmholtz Ctr Munich, Inst Epidemiol 2, Neuherberg, Germany
[31] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany
[32] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[33] Med Univ Vienna, Dept Epidemiol, Vienna, Austria
基金
瑞典研究理事会; 美国国家卫生研究院; 英国医学研究理事会; 加拿大健康研究院;
关键词
circadian rhythm; melatonin; prostate cancer; cancer; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DNA-DAMAGE; SHIFT-WORK; CELL-PROLIFERATION; COLORECTAL-CANCER; LUNG-CANCER; NIGHT WORK; CLOCK; MELATONIN;
D O I
10.1002/ijc.30883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circadian disruption has been linked to carcinogenesis in animal models, but the evidence in humans is inconclusive. Genetic variation in circadian rhythm genes provides a tool to investigate such associations. We examined associations of genetic variation in nine core circadian rhythm genes and six melatonin pathway genes with risk of colorectal, lung, ovarian and prostate cancers using data from the Genetic Associations and Mechanisms in Oncology (GAME-ON) network. The major results for prostate cancer were replicated in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial, and for colorectal cancer in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). The total number of cancer cases and controls was 15,838/18,159 for colorectal, 14,818/14,227 for prostate, 12,537/17,285 for lung and 4,369/9,123 for ovary. For each cancer site, we conducted gene-based and pathway-based analyses by applying the summary-based Adaptive Rank Truncated Product method (sARTP) on the summary association statistics for each SNP within the candidate gene regions. Aggregate genetic variation in circadian rhythm and melatonin pathways were significantly associated with the risk of prostate cancer in data combining GAME-ON and PLCO, after Bonferroni correction (rho(pathway) < 0.00625). The two most significant genes were NPAS2 (rho(gene) = 0.0062) and AANAT (rho(gene) = 0.00078); the latter being significant after Bonferroni correction. For colorectal cancer, we observed a suggestive association with the circadian rhythm pathway in GAME-ON (peat,way = 0.021); this association was not confirmed in GECCO (rho(pathway) = 0.76) or the combined data In (rho(pathway) = 0.17). No significant association was observed for ovarian and lung cancer. These findings support a potential role for circadian rhythm and melatonin pathways in prostate carcinogenesis. Further functional studies are needed to better understand the underlying biologic mechanisms.
引用
收藏
页码:1794 / 1802
页数:9
相关论文
共 50 条
  • [41] Circadian Rhythm Gene PER3 Negatively Regulates Stemness of Prostate Cancer Stem Cells via WNT/β-Catenin Signaling in Tumor Microenvironment
    Li, Qilin
    Xia, Ding
    Wang, Zhihua
    Liu, Bo
    Zhang, Jing
    Peng, Ping
    Tang, Qiujun
    Dong, Jie
    Guo, Juan
    Kuang, Dong
    Chen, Weimin
    Mao, Jing
    Li, Qiuhui
    Chen, Xin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer
    Yuan, Wenliang
    Liu, Li
    Wei, Cai
    Li, Xiaobo
    Sun, Dan
    Dai, Chaoxu
    Li, Sicong
    Peng, Sihua
    Jiang, Linhua
    ONCOLOGY LETTERS, 2019, 18 (05) : 4816 - 4824
  • [43] The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials
    Yap, Tet
    Ahmed, Hashim U.
    Hindley, Richard G.
    Guillaumier, Stephanie
    McCartan, Neil
    Dickinson, Louise
    Emberton, Mark
    Minhas, Suks
    EUROPEAN UROLOGY, 2016, 69 (05) : 844 - 851
  • [44] Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer
    Valicenti, RK
    Sweet, JW
    Hauck, WW
    Hudes, RS
    Lee, T
    Dicker, AP
    Waterman, FM
    Anne, PR
    Corn, BW
    Galvin, JM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (04): : 931 - 935
  • [45] Three-dimensional summation of rectal doses in brachytherapy combined with external beam radiotherapy for prostate cancer
    Kikuchi, Koyo
    Nakamura, Ryuji
    Tanji, Susumu
    Yamaguchi, Satoshi
    Kakuhara, Hisao
    Yabuuchi, Tomonori
    Inatsu, Wakako
    Oikawa, Hirobumi
    Ariga, Hisanori
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (02) : 159 - 164
  • [46] Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study
    Agalliu, Ilir
    Kwon, Erika M.
    Salinas, Claudia A.
    Koopmeiners, Joseph S.
    Ostrander, Elaine A.
    Stanford, Janet L.
    CANCER CAUSES & CONTROL, 2010, 21 (02) : 289 - 300
  • [47] Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial
    Yang, Hannah P.
    Woodson, Karen
    Taylor, Philip R.
    Pietinen, Pirjo
    Albanes, Demetrius
    Virtamo, Jarmo
    Tangrea, Joseph A.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2006, 15 (03) : 249 - 253
  • [48] Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study
    Ilir Agalliu
    Erika M. Kwon
    Claudia A. Salinas
    Joseph S. Koopmeiners
    Elaine A. Ostrander
    Janet L. Stanford
    Cancer Causes & Control, 2010, 21 : 289 - 300
  • [49] Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer
    Nora Tabea Sibert
    Holger Pfaff
    Clara Breidenbach
    Simone Wesselmann
    Rebecca Roth
    Günther Feick
    Günter Carl
    Sebastian Dieng
    Amr A. Gaber
    Andreas Blana
    Christopher Darr
    Florian Distler
    Frank Kunath
    Jens Bedke
    Jörg Erdmann
    Jörg Minner
    Jörg Simon
    Maciej Kwiatkowski
    Martin Burchardt
    Nino Harz
    Stefan Conrad
    Thomas Höfner
    Thomas Knoll
    Burkhard Beyer
    Peter Hammerer
    Christoph Kowalski
    World Journal of Urology, 2022, 40 : 1437 - 1446
  • [50] Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer
    Sibert, Nora Tabea
    Pfaff, Holger
    Breidenbach, Clara
    Wesselmann, Simone
    Roth, Rebecca
    Feick, Guenther
    Carl, Guenter
    Dieng, Sebastian
    Gaber, Amr A.
    Blana, Andreas
    Darr, Christopher
    Distler, Florian
    Kunath, Frank
    Bedke, Jens
    Erdmann, Joerg
    Minner, Joerg
    Simon, Joerg
    Kwiatkowski, Maciej
    Burchardt, Martin
    Harz, Nino
    Conrad, Stefan
    Hoefner, Thomas
    Knoll, Thomas
    Beyer, Burkhard
    Hammerer, Peter
    Kowalski, Christoph
    WORLD JOURNAL OF UROLOGY, 2022, 40 (06) : 1437 - 1446